Authors
Latest:
Private-payer Costs for Employees with Treatment-resistant DepressionIndividuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Latest:
The Case for Establishing a Residency Program in Specialty PharmacyPharmacy residency programs offer postgraduate training to launch pharmacists from their formal education into successful careers.
Latest:
The 7 Habits of Highly Effective Pharmacy Students and InternsCan we teach effective habits? Is there a blueprint for helping pharmacy students and interns be more proactive, prioritize more efficiently, and embrace a strong work ethic?
Latest:
Daily Dose and Costs of Therapy With Topical Testosterone AgentsWe assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.
Latest:
Risky Business: Overanticoagulation from High-Risk Antimicrobials and WarfarinWarfarin is the most commonly prescribed anticoagulant in the United States, having been indicated for the treatment and prevention of venous thromboembolism and the prevention of thromboembolic complications.
Latest:
Helping Baltimoreans Safely Dispose of MedicationOn Wednesday, October 24, and Saturday, October 27, student pharmacists from the University of Maryland School of Pharmacy chapter of the APhA-ASP joined forces with the University of Maryland, Baltimore Police and the Drug Enforcement Administration (DEA) to host our bi-annual Drug Take-Back Day at the University’s SMC Campus Center.
Latest:
Drug Diversion: New Approaches to an Old ProblemDrug diversion in hospitals continues to be problematic. Heightened DEA activity and opioid addiction reaching epidemic proportions require hospitals to be more vigilant than ever.
Latest:
Making the 2016 Marketplace More Patient FocusedThe time is now to develop a consensus on how patient needs, health plan sustainability, and government regulations intertwine to create a more patient-focused insurance marketplace.
Latest:
Medication Nonadherence in the Latino Population: A Challenge and an Opportunity for Specialized ServicesAs US demographics steadily shift towards minorities and immigrants from diverse backgrounds, health care workers must be prepared to face new cultural challenges that may impact health behaviors, including medication adherence in these populations.
Latest:
Hepatitis C Combinations Show Similar Efficacy Profiles in Genotypes 2, 3Treatment regimens consisting of daclatasvir plus sofosbuvir plus ribavirin and velpatasvir/sofosbuvir plus ribavirin show similar cure rates in patients with hepatitis C virus genotype 2 and 3.
Latest:
The Impact of Physical Activity on Parkinson Disease ProgressionResearch has also shown that patients with Parkinson disease who are able to engage in physical activity can potentially improve the motor and non-motor symptoms associated with the disease.
Latest:
Biologic Management for IBDWith increased specialty medication prescribing, associated costs, and the interest of health systems to establish specialty pharmacies for improved patient care, it is vital to define the pharmacist's role within the patient's health care team.
Latest:
Multiple SclerosisAlthough the research has consistently shown that individuals deficient in vitamin D seem to be at an increased risk for developing multiple sclerosis (MS), there has been some debate on what level of vitamin D may protect against MS.
Latest:
Maximizing Patient Experience with the Addition of Chat TechnologyChat communication offers convenience and access to accurate clinical information.
Latest:
Multiple Sclerosis ManagementSymptomatic and disease-modifying treatment options for multiple sclerosis.
Latest:
Combating Advancing Cancers With CAR T-Cell TherapyImmunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Latest:
Outcomes Associated With Primary and Secondary Nonadherence to Cholesterol MedicationsThis study evaluates the impact of primary and secondary nonadherence to cholesterol medication on low-density lipoprotein levels, emergency department visits, and hospitalizations.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Latest:
Outpatient Cancer Center Cost Evaluation of Extended Beyond-Use Dating with a Closed-System Transfer DeviceThere is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.
Latest:
Implications of the CMMI Enhanced Medication Therapy Management Program for the Future of Community PharmacyIn 2006, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 was implemented, marking the launch of medication therapy management services under Medicare Part D.
Latest:
Can Blockchain Play a Role in Revamping Health Care?Health care costs in the US represent nearly 20% of the GDP.
Latest:
Hepatitis C TreatmentThere are now 8 FDA approved medications for HCV treatment, all of which bypass the use of interferon.
Latest:
Using Technology for Patient Engagement: Are We There Yet?New tools and platforms can help pharmacists to support patients.
